$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The Notch signaling pathway is a highly conserved pathway that is important for many developmental processes within biological organisms. Notch signaling has been shown to play a significant role in cell proliferation and self-renewal, and defects in the Notch signaling pathway can lead to many types of cancers1,2,3,4,5,6. In some circumstances, the Notch signaling pathway has been linked to both tissue growth and cancer as well as cell death and tumor suppression7. Multiple Notch receptors (NOTCH 1−4) and co‒activator Mastermind (MAML 1−3), all with diverse functions, add an additional level of complexity. While the Notch signaling pathway is sophisticated in terms of functions, its core pathway is simple on a molecular basis8. Notch receptors act as transmembrane proteins composed of extracellular and intracellular regions9. A ligand binding to the extracellular region of Notch receptors facilitates proteolytic cleavage, which allows the Notch intracellular domain (NICD) to be released into the nucleus. NICD then binds to co‒activator Mastermind to activate downstream gene expression10.
In recent years, Notch signaling has been shown to play a variety of roles in the initiation and progression of several types of cancers across different species6,11. For instance, Notch signaling has been linked to tumorigenesis involving the human NOTCH1 gene12. Recently, the NOTCH2, NOTCH3, Delta-like 3 (DLL3), Mastermind‒like protein 1 (MAML1), and a disintegrin and metalloproteinase domain‒containing protein 17 (ADAM17) genes were shown to be strongly associated with ovarian cancer, especially with the poor overall survival of patients13.
As the amount of experimental and patient-associated data continuously increases, the demand for analysis of the available data increases as well. The available data are scattered across publications, and they may deliver inconsistent or even contradictory findings. With the development of new technology in recent decades, such as next-generation sequencing, the amount of available data has grown exponentially. Although this represents rapid advancements in science and opportunities for continued biological research, assessing the meaning of publicly available data to solve research questions is a great challenge14. We believe bioinformatics is a useful way to extract smaller pieces of information from large-scale datasets. Through the implementation of various bioinformatics approaches, researchers can quickly, reliably, and efficiently interpret these large datasets, yielding insightful discoveries. These discoveries may range from the identification of potential new drug therapy targets or disease biomarkers, to personalized patient treatments15,16.
Bioinformatics itself is rapidly evolving, and approaches are constantly changing as technological advances sweep medical and biological science. Currently, common bioinformatics approaches include the utilization of publicly accessible databases and software programs to analyze DNA or protein sequences, identify genes of particular relevance or importance, and determine the relevance of genes and gene products through functional genomics16. Although the field of bioinformatics is certainly not limited to these approaches, these are significant in helping clinicians and researchers manage biological data for the benefit of patients as a whole.
This study aims to highlight several important databases and their use for research about the Notch signaling pathway. NOTCH2, NOTCH3, and their co‒activator MAML1 were used as examples for the database study. These genes were used because the importance of the Notch signaling pathway in ovarian cancer has been validated. Systematic analyses of retrieved data confirmed the importance of Notch signaling in ovarian cancer. In addition, because Notch signaling is well conserved across species, it was confirmed that overexpression of Drosophila melanogaster NICD and Mastermind together can induce tumors in Drosophila ovaries, supporting the database findings and the significant and conserved role of Notch signaling in ovarian cancer.